Cargando…

Thrombomodulin/activated protein C system in septic disseminated intravascular coagulation

The thrombomodulin (TM)/activated protein C (APC) system plays an important role in maintaining the homeostasis of thrombosis and hemostasis and maintaining vascular integrity in vivo. TM expressed on vascular endothelium binds to thrombin, forming a 1:1 complex and acts as an anticoagulant. In addi...

Descripción completa

Detalles Bibliográficos
Autor principal:	Ikezoe, Takayuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336127/ https://www.ncbi.nlm.nih.gov/pubmed/25705426 http://dx.doi.org/10.1186/s40560-014-0050-7

Ejemplares similares

Clinical efficacy of recombinant human soluble thrombomodulin in patients with septic disseminated intravascular coagulation
por: Suzuki, Y, et al.
Publicado: (2013)

Management of disseminated intravascular coagulation: current insights on antithrombin and thrombomodulin treatments
por: Hayakawa, Mineji
Publicado: (2017)

Efficacy of recombinant human soluble thrombomodulin in disseminated intravascular coagulation
por: Yasuda, T, et al.
Publicado: (2010)

Adequate application of recombinant thrombomodulin for sepsis-associated disseminated intravascular coagulation
por: Iba, Toshiaki
Publicado: (2015)

Effect of Thrombomodulin Alfa on Disseminated Intravascular Coagulation in Patients with Lung Cancer
por: Nakano, Kentaro, et al.
Publicado: (2017)

Effectiveness of combined antithrombin and thrombomodulin therapy on in-hospital mortality in mechanically ventilated septic patients with disseminated intravascular coagulation
por: Umegaki, Takeshi, et al.
Publicado: (2020)

Prognostic factors in patients with septic disseminated intravascular coagulation treated with thrombomodulin: the effect of reduced thrombomodulin dose; a single-center, retrospective, observational study
por: Nishita, Yoshihiro, et al.
Publicado: (2022)

Use of Antithrombin and Thrombomodulin in the Management of Disseminated Intravascular Coagulation in Patients with Acute Cholangitis
por: Nakahara, Kazunari, et al.
Publicado: (2013)

TAFRO Syndrome with Disseminated Intravascular Coagulation Successfully Treated with Tocilizumab and Recombinant Thrombomodulin
por: Takayama, Yusuke, et al.
Publicado: (2017)

Thrombomodulin in disseminated intravascular coagulation and other critical conditions—a multi-faceted anticoagulant protein with therapeutic potential
por: Ito, Takashi, et al.
Publicado: (2019)

Benefit Profile of Thrombomodulin Alfa Combined with Antithrombin Concentrate in Patients with Sepsis-Induced Disseminated Intravascular Coagulation
por: Murao, Atsushi, et al.
Publicado: (2022)

Pharmacokinetics of Standard- and Reduced-Dose Recombinant Human Soluble Thrombomodulin in Patients with Septic Disseminated Intravascular Coagulation during Continuous Hemodiafiltration
por: Watanabe, Eizo, et al.
Publicado: (2017)

Effects of combination therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation
por: Iba, Toshiaki, et al.
Publicado: (2017)

Diagnosis and treatment of disseminated intravascular coagulation in COVID-19 patients: a scoping review
por: Mori, Hirotaka, et al.
Publicado: (2021)

The efficacy of recombinant human soluble thrombomodulin for obstetric disseminated intravascular coagulation: a retrospective study
por: Yoshihara, Masato, et al.
Publicado: (2015)

Thrombomodulin phenotype of a distinct monocyte subtype is an independent prognostic marker for disseminated intravascular coagulation
por: Hwang, Sang Mee, et al.
Publicado: (2011)

Clinical Impact of Recombinant Soluble Thrombomodulin for Disseminated Intravascular Coagulation Associated with Severe Acute Cholangitis
por: Okuda, Atsushi, et al.
Publicado: (2018)

Pharmacokinetics of Recombinant Human Soluble Thrombomodulin in Disseminated Intravascular Coagulation Patients with Acute Renal Dysfunction
por: Hayakawa, Mineji, et al.
Publicado: (2017)

Efficacy of Combined Thrombomodulin and Antithrombin in Anticoagulant Therapy for Acute Cholangitis-induced Disseminated Intravascular Coagulation
por: Morita, Nozomi, et al.
Publicado: (2018)

A summary of the Japan septic disseminated intravascular coagulation study
por: Hayakawa, Mineji, et al.
Publicado: (2018)

Disseminated intravascular coagulation
por: Venugopal, A
Publicado: (2014)

Performances of disseminated intravascular coagulation scoring systems in septic shock patients
por: Helms, Julie, et al.
Publicado: (2020)

Analysis of the association between resolution of disseminated intravascular coagulation (DIC) and treatment outcomes in post-marketing surveillance of thrombomodulin alpha for DIC with infectious disease and with hematological malignancy by organ failure
por: Kawano, Noriaki, et al.
Publicado: (2020)

Successful treatment of disseminated intravascular coagulation by recombinant human soluble thrombomodulin in patients with acute myeloid leukemia
por: Ookura, Miyuki, et al.
Publicado: (2018)

Factors influencing the effectiveness of recombinant human soluble thrombomodulin on disseminated intravascular coagulation: a retrospective study
por: Asai, Yuki, et al.
Publicado: (2020)

Hypofibrinogenemia is associated with a high degree of risk in infectious diseases: a post-hoc analysis of post-marketing surveillance of patients with disseminated intravascular coagulation treated with thrombomodulin alfa
por: Kawasugi, Kazuo, et al.
Publicado: (2021)

Preliminary study of microparticle coagulation properties in septic patients with disseminated intravascular coagulation
por: Meng, Shishuai, et al.
Publicado: (2021)

Clinical Features of Disseminated Intravascular Coagulation According to the French-American-British Classification in Patients With Acute Leukemia and Thrombomodulin Alfa Treatment—A Cohort Study Using a Postmarketing Surveillance Database
por: Yoshinobu, Seki, et al.
Publicado: (2021)

Is early treatment of disseminated intravascular coagulation beneficial in septic patients?
por: Wada, Hideo, et al.
Publicado: (2014)

The place of plasmapheresis in septic patients complicated with disseminated intravascular coagulation
por: Oral, M, et al.
Publicado: (2004)

Sepsis and disseminated intravascular coagulation
por: Okamoto, Kohji, et al.
Publicado: (2016)

The effect of recombinant human soluble thrombomodulin on renal function and mortality in septic disseminated intravascular coagulation patients with acute kidney injury: a retrospective study
por: Akatsuka, Masayuki, et al.
Publicado: (2020)

Use of Recombinant Human Soluble Thrombomodulin in Patients with Sepsis-Induced Disseminated Intravascular Coagulation after Intestinal Perforation
por: Tagami, Takashi, et al.
Publicado: (2015)

Recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis
por: Yamakawa, Kazuma, et al.
Publicado: (2013)

Post-marketing surveillance data of thrombomodulin alfa: sub-analysis in patients with sepsis-induced disseminated intravascular coagulation
por: Eguchi, Yutaka, et al.
Publicado: (2014)

NINJ1 Regulates Platelet Activation and PANoptosis in Septic Disseminated Intravascular Coagulation
por: Zhou, Xiaoli, et al.
Publicado: (2023)

Corrigendum to “Preliminary study of microparticle coagulation properties in septic patients with disseminated intravascular coagulation”
Publicado: (2022)

Renal thrombotic microangiopathy in a patient with septic disseminated intravascular coagulation
por: Sakamaki, Yusuke, et al.
Publicado: (2013)

Clinical study on the cerebral infarction accompanied with septic disseminated intravascular coagulation
por: Kako, Tetsuharu, et al.
Publicado: (2021)

Effect of Recombinant Human Soluble Thrombomodulin on Coagulation-Related Variables in Patients With Sepsis-Induced Disseminated Intravascular Coagulation: A Retrospective Observational Study
por: Mitaka, Chieko, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g3djrm5qh2l6ud5fm7n9h7d4hi